Attached files
| file | filename |
|---|---|
| 8-K - Hill-Rom Holdings, Inc. | s861508k.htm |
Exhibit 99.1
CONTACT INFORMATION
Investor Relations
|
Contact:
|
Blair A. (Andy) Rieth, Jr., Vice President, Investor Relations
|
|
Phone:
|
312-819-7259
|
|
Email:
|
andy.rieth@hill-rom.com
|
Media
|
Contact:
|
Larry Baumann, Executive Director, Corporate Communications
|
|
Phone:
|
312-819-7248
|
|
Email:
|
larry.baumann@hill-rom.com
|
HILL-ROM REPORTS STRONG THIRD QUARTER
RESULTS; UPDATES 2015 ADJUSTED EARNINGS OUTLOOK
|
|
·
|
Reported revenue increased 19 percent from prior year to $475 million, on the strength of 11 percent organic, constant currency growth
|
|
|
·
|
Adjusted diluted earnings per share of $0.62 compare to $0.59 in the prior year
|
|
|
·
|
Reported diluted earnings per share of $0.33 compare to $0.45 in the prior year
|
|
|
·
|
Year to date operating cash flow of $124 million compares to $134 million in the prior year
|
|
|
·
|
Full year adjusted earnings per share are now expected to be $2.51 to $2.54; Full-year reported revenue is now expected to grow 12 to 13 percent
|
CHICAGO, Ill., August 7, 2015 -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its third quarter ended June 30, 2015 and updated its 2015 financial outlook. Adjusted earnings per diluted share of $0.62 increased 5 percent from $0.59 in the prior year, while reported earnings per diluted share of $0.33 decreased from $0.45. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
Hill-Rom’s quarterly revenue of $475 million increased 19 percent compared to last year, or 26 percent on a constant currency basis, primarily due to the Trumpf Medical acquisition and strong North America capital revenue growth. Excluding the benefit of Trumpf, our constant currency growth was 11 percent, driven primarily by 25 percent growth in the North America capital business. Domestic revenue was $308 million, up 21 percent, while revenue outside the United States of $167 million increased 36 percent on a constant currency basis.
Management Comments
“We are pleased to report another quarter of strong revenue and adjusted earnings growth. Our double-digit organic revenue growth was driven by strength in our North America capital business, which increased 25 percent in the quarter,” said John Greisch, Hill-Rom President and Chief Executive Officer. “In addition, we accelerated our growth strategy with our agreement to acquire Welch Allyn. We are confident that our combination with Welch Allyn will advance our strategic objectives and create a stronger platform from which to deliver increased shareholder value.”
Third Quarter Financial Results and Operational Highlights
-- Revenue:
-- North America. North America revenue increased 19 percent to $252 million. On a constant currency basis, capital sales increased 25 percent, while rental revenue increased 15 percent, excluding the impact of the previously exited third party reimbursed home care rental business. As reported, rental revenue grew 9 percent.
-- International. International segment revenue was flat on a constant currency basis and was down 15 percent on a reported basis to $102 million. On a constant currency basis, capital revenue was flat with the prior year, while rental revenue decreased 2 percent.
-- Surgical/Respiratory Care. Surgical and Respiratory Care revenue increased 81 percent to $120 million, or 94 percent on a constant currency basis, reflecting 3 percent organic constant currency growth plus the addition of Trumpf Medical.
|
--
|
Year to date operating cash flow was $124 million compared to $134 million in the prior year.
|
Welch Allyn Acquisition
As previously announced, Hill-Rom and Welch Allyn entered into a definitive merger agreement for Hill-Rom to acquire Welch Allyn for approximately $2.05 billion in cash and stock. Hill-Rom expects the transaction will close on or before October 1, 2015, subject to customary closing conditions.
Please see the attached schedules for additional information, including condensed financial information, a summary balance sheet, a cash flow statement and reconciliations of GAAP to adjusted financial measures.
For a more complete review of Hill-Rom’s results, please refer to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015.
Financial Guidance Summary
All financial guidance excludes the effects of Welch Allyn, including all costs and cash flows necessary to complete the acquisition.
Revenue: For fiscal 2015, Hill-Rom expects reported revenue growth of 12 to 13 percent, compared to 10 to 11 percent previously. This reflects:
|
|
·
|
mid-single-digit constant currency organic growth, compared to low-to-mid-single digit growth previously; and
|
|
|
·
|
negative currency impact of approximately 6 percent.
|
For the fourth quarter of fiscal 2015, Hill-Rom expects reported revenue growth of 1 to 3 percent. This reflects:
|
|
·
|
low-single-digit constant currency organic growth; and
|
|
|
·
|
negative currency impact of approximately 5 percent.
|
Adjusted Earnings per Diluted Share: The Company expects full year adjusted earnings per diluted share to be $2.51 to $2.54, compared to $2.50 to $2.54 previously.
Fourth quarter adjusted earnings per diluted share are expected to be $0.76 to $0.79.
Cash Flow: Hill-Rom now expects cash flow from operations for the full year to be approximately $235 million, compared to $250 million previously. Capital expenditures are now expected to be $125 million, compared to $140 million previously.
Discussion of Adjusted Financial Measures
Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company’s management believes that the presentation provides useful information to investors. This measure excludes strategic developments, special charges or other unusual events. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company's reported operations for a period. Often, prospective quantification of such items is not feasible.
The Company also excludes expenses associated with the amortization of intangible assets associated with prior business acquisitions. This adjustment is made to allow investors to evaluate and understand operating trends excluding the non-cash impact of acquired intangible amortization on operating income, earnings per share and other measures.
Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.
Reconciliations of GAAP measures to adjusted measures appear in the financial tables of this release.
Conference Call Webcast and Dial-in Information
As previously announced, the Company will host a conference call and webcast today at 8:00 a.m. ET.
Webcast: To join the live webcast with audio, go to http://ir.hill-rom.com/events.cfm or http://edge.media-server.com/m/p/e2nx89pd. The webcast slide deck will be posted to the Hill-Rom website prior to the webcast.
Conference Call Audio Only Dial-in information: To join the live conference call, dial 877-304-8969 domestic callers / 631-291-4543 international callers. The following Confirmation Code is required for both: 77812606. Callers will need to provide their name, company affiliation and telephone number to the conference operator. A recording of the webcast/call audio will be available for telephone replay through August 13, 2015, domestically at 855-859-2056 and internationally at 404-537-3406. For the replay, callers will need to use confirmation code 77812606. If you are unable to listen to the live webcast or the telephone replay, the webcast will be archived at http://ir.hill-rom.com/events.cfm.
About Hill-Rom Holdings, Inc.
Hill-Rom is a leading global medical technology company with approximately 8,000 employees worldwide. We partner with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. Around the world, Hill-Rom's people, products, and programs work towards one mission: Enhancing outcomes for patients and their caregivers.
www.hill-rom.com
Disclosure Regarding Forward Looking Statements
Certain statements herein contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company’s future plans, objectives, beliefs, expectations, representations and projections. It is important to note that forward-looking statements are not guarantees of future performance, and the Company’s actual results could differ materially from those set forth in any forward-looking statements. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading “Risk Factors” in the Company’s previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or revise any forward-looking statements.
Additional Information and Where to Find It. Hill-Rom has filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 to register shares of Hill-Rom common stock that will be issued to Welch Allyn shareholders in connection with the transaction, which includes a proxy statement/prospectus that will be delivered to Welch Allyn's shareholders in connection with their required approval of the transaction. INVESTORS AND SECURITYHOLDERS OF WELCH ALLYN ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER FILINGS THAT MAY BE MADE WITH THE SEC IN CONNECTION WITH THE TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION. The registration statement and proxy statement/prospectus and other documents which will be filed by Hill-Rom with the SEC, when filed, will be available free of charge at the SEC's website at www.sec.gov, or from Hill-Rom, 180 North Stetson Avenue, Suite 4100, Chicago, IL 60601, Attention Corporate Secretary. Certain executive officers and directors of Welch Allyn have interests in the proposed transaction that may differ from the interests of stockholders generally. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to appropriate registration or qualification under the securities laws of such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
###
Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(Dollars in millions, except per share data)
(unaudited)
|
Quarter Ended June 30
|
Year To Date Ended June 30
|
|||||||||||||||
|
2015
|
2014
|
2015
|
2014
|
|||||||||||||
|
Net revenue
|
||||||||||||||||
|
Capital sales
|
$ | 376.8 | $ | 302.8 | $ | 1,125.9 | $ | 911.9 | ||||||||
|
Rental revenue
|
97.7 | 94.8 | 288.4 | 294.4 | ||||||||||||
|
Total revenue
|
474.5 | 397.6 | 1,414.3 | 1,206.3 | ||||||||||||
|
Cost of revenue
|
||||||||||||||||
|
Cost of goods sold
|
217.9 | 168.2 | 652.3 | 508.9 | ||||||||||||
|
Rental expenses
|
47.1 | 42.3 | 138.4 | 130.8 | ||||||||||||
|
Total cost of revenue
|
265.0 | 210.5 | 790.7 | 639.7 | ||||||||||||
|
Gross profit
|
||||||||||||||||
|
Capital
|
158.9 | 134.6 | 473.6 | 403.0 | ||||||||||||
|
Rental
|
50.6 | 52.5 | 150.0 | 163.6 | ||||||||||||
|
Total gross profit
|
209.5 | 187.1 | 623.6 | 566.6 | ||||||||||||
|
As a percentage of sales
|
44.2 | % | 47.1 | % | 44.1 | % | 47.0 | % | ||||||||
|
Research and development expenses
|
23.3 | 17.5 | 67.3 | 50.3 | ||||||||||||
|
Selling and administrative expenses
|
150.5 | 128.6 | 455.5 | 396.7 | ||||||||||||
|
Special charges
|
4.4 | 3.0 | 11.9 | 32.4 | ||||||||||||
|
Operating profit
|
31.3 | 38.0 | 88.9 | 87.2 | ||||||||||||
|
Other income/(expense), net
|
(3.3 | ) | (1.7 | ) | (7.3 | ) | (6.2 | ) | ||||||||
|
Income tax expense
|
9.3 | 10.2 | 24.7 | 45.0 | ||||||||||||
|
Net income
|
18.7 | 26.1 | 56.9 | 36.0 | ||||||||||||
|
Less: Net loss attributable to noncontrolling interests
|
(0.4 | ) | - | (0.4 | ) | - | ||||||||||
|
Net income attributable to common shareholders
|
$ | 19.1 | $ | 26.1 | $ | 57.3 | $ | 36.0 | ||||||||
|
Diluted earnings per share:
|
||||||||||||||||
|
Earnings per share
|
$ | 0.33 | $ | 0.45 | $ | 0.99 | $ | 0.61 | ||||||||
|
Average common shares outstanding - diluted (thousands)
|
57,899 | 58,160 | 57,943 | 58,499 | ||||||||||||
|
Dividends per common share
|
$ | 0.1600 | $ | 0.1525 | $ | 0.4725 | $ | 0.4425 | ||||||||
Non-GAAP Financial Disclosures and Reconciliations
While Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. Hill-Rom uses non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.
Hill-Rom Holdings, Inc. and Subsidiaries
Revenue - Constant Currency
(Dollars in millions)
|
Quarter Ended June 30
|
||||||||||||||||||||
|
2015
As Reported
|
Foreign Exchange
Impact
|
2015
Adjusted
|
2014
As Reported
|
Constant Currency
Change
|
||||||||||||||||
|
Capital sales
|
$ | 376.8 | $ | (24.9 | ) | $ | 401.7 | $ | 302.8 | 32.7 | % | |||||||||
|
Rental revenue
|
97.7 | (2.3 | ) | 100.0 | 94.8 | 5.5 | % | |||||||||||||
|
Total
|
$ | 474.5 | $ | (27.2 | ) | $ | 501.7 | $ | 397.6 | 26.2 | % | |||||||||
|
North America
|
$ | 252.4 | $ | (1.5 | ) | $ | 253.9 | $ | 211.6 | 20.0 | % | |||||||||
|
Surgical and Respiratory Care
|
119.7 | (8.7 | ) | 128.4 | 66.2 | 94.0 | % | |||||||||||||
|
International
|
102.4 | (17.0 | ) | 119.4 | 119.8 | -0.3 | % | |||||||||||||
|
Total
|
$ | 474.5 | $ | (27.2 | ) | $ | 501.7 | $ | 397.6 | 26.2 | % | |||||||||
|
Year To Date Ended June 30
|
||||||||||||||||||||
|
2015
As Reported
|
Foreign Exchange
Impact
|
2015
Adjusted
|
2014
As Reported
|
Constant Currency
Change
|
||||||||||||||||
|
Capital sales
|
$ | 1,125.9 | $ | (63.4 | ) | $ | 1,189.3 | $ | 911.9 | 30.4 | % | |||||||||
|
Rental revenue
|
288.4 | (5.6 | ) | 294.0 | 294.4 | -0.1 | % | |||||||||||||
|
Total
|
$ | 1,414.3 | $ | (69.0 | ) | $ | 1,483.3 | $ | 1,206.3 | 23.0 | % | |||||||||
|
North America
|
$ | 724.5 | $ | (4.0 | ) | $ | 728.5 | $ | 641.6 | 13.5 | % | |||||||||
|
Surgical and Respiratory Care
|
366.0 | (22.8 | ) | 388.8 | 195.1 | 99.3 | % | |||||||||||||
|
International
|
323.8 | (42.2 | ) | 366.0 | 369.6 | -1.0 | % | |||||||||||||
|
Total
|
$ | 1,414.3 | $ | (69.0 | ) | $ | 1,483.3 | $ | 1,206.3 | 23.0 | % | |||||||||
Hill-Rom Holdings, Inc. and Subsidiaries
Reconciliation: Earnings Per Share
(Dollars in millions, except per share data)
|
Quarter Ended June 30, 2015
|
Quarter Ended June 30, 2014
|
|||||||||||||||||||||||||||
|
Income Before
Income Taxes
|
Income Tax
Expense
|
NCI
|
Diluted EPS#
|
Income Before
Income Taxes
|
Income Tax
Expense
|
Diluted EPS
|
||||||||||||||||||||||
|
GAAP Earnings
|
$ | 28.0 | $ | 9.3 | $ | (0.4 | ) | $ | 0.33 | $ | 36.3 | $ | 10.2 | $ | 0.45 | |||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||||||
|
Acquisition and integration costs
|
6.8 | 2.3 | - | 0.08 | 2.8 | 1.0 | 0.03 | |||||||||||||||||||||
|
Acquisition-related intangible asset amortization
|
7.7 | 2.1 | - | 0.10 | 7.1 | 2.1 | 0.08 | |||||||||||||||||||||
|
Employee benefits change
|
- | - | - | - | (1.2 | ) | (0.4 | ) | (0.01 | ) | ||||||||||||||||||
|
FDA remediation expenses
|
1.3 | 0.4 | - | 0.02 | 1.1 | 0.5 | 0.01 | |||||||||||||||||||||
|
Field corrective actions
|
2.6 | 0.8 | - | 0.03 | (1.0 | ) | 0.2 | (0.02 | ) | |||||||||||||||||||
|
Litigation settlements and expenses
|
0.3 | 0.1 | - | - | - | - | - | |||||||||||||||||||||
|
Special charges
|
4.4 | 0.9 | - | 0.06 | 3.0 | 0.2 | 0.05 | |||||||||||||||||||||
|
Adjusted Earnings
|
$ | 51.1 | $ | 15.9 | $ | (0.4 | ) | $ | 0.62 | $ | 48.1 | $ | 13.8 | $ | 0.59 | |||||||||||||
|
Year to Date Ended June 30, 2015
|
Year to Date Ended June 30, 2014
|
|||||||||||||||||||||||||||
|
Income Before
Income Taxes
|
Income Tax
Expen se
|
NCI
|
Diluted EPS*#
|
Income Before
Income Taxes
|
Income Tax
Expense
|
Diluted EPS
|
||||||||||||||||||||||
|
GAAP Earnings
|
$ | 81.6 | $ | 24.7 | $ | (0.4 | ) | $ | 0.99 | $ | 81.0 | $ | 45.0 | $ | 0.61 | |||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||||||
|
Acquisition and integration costs
|
19.5 | 6.3 | - | 0.23 | 6.4 | 2.2 | 0.07 | |||||||||||||||||||||
|
Acquisition-related intangible asset amortization
|
23.4 | 6.5 | - | 0.29 | 20.9 | 6.3 | 0.25 | |||||||||||||||||||||
|
Employee benefits change
|
- | - | - | - | (13.4 | ) | (5.1 | ) | (0.14 | ) | ||||||||||||||||||
|
FDA remediation expenses
|
3.0 | 1.0 | - | 0.03 | 2.8 | 1.1 | 0.03 | |||||||||||||||||||||
|
Field corrective actions
|
4.9 | 1.5 | - | 0.06 | (1.7 | ) | (0.6 | ) | (0.02 | ) | ||||||||||||||||||
|
Litigation settlements and expenses
|
(0.6 | ) | (0.2 | ) | - | (0.01 | ) | - | - | - | ||||||||||||||||||
|
Special charges
|
11.9 | 1.2 | 0.18 | 32.4 | 10.5 | 0.37 | ||||||||||||||||||||||
|
Foreign valuation allowance
|
- | 1.9 | - | (0.03 | ) | - | (19.6 | ) | 0.34 | |||||||||||||||||||
|
Adjusted Earnings
|
$ | 143.7 | $ | 42.9 | $ | (0.4 | ) | $ | 1.75 | $ | 128.4 | $ | 39.8 | $ | 1.51 | |||||||||||||
* Does not add due to rounding.
# Diluted EPS column is shown on an attributable to common shareholders basis.
NCI = Net loss attributable to noncontrolling interests
Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Dollars in millions)
(unaudited)
|
June 30, 2015
|
September 30, 2014
|
|||||||
|
Assets
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$ | 123.4 | $ | 99.3 | ||||
|
Trade accounts receivable, net of allowances
|
390.6 | 411.0 | ||||||
|
Inventories, net
|
169.9 | 176.2 | ||||||
|
Other current assets
|
97.5 | 92.8 | ||||||
|
Total current assets
|
781.4 | 779.3 | ||||||
|
Property, plant and equipment, net
|
287.5 | 261.5 | ||||||
|
Goodwill
|
406.3 | 399.8 | ||||||
|
Other assets
|
282.3 | 311.5 | ||||||
|
Total Assets
|
$ | 1,757.5 | $ | 1,752.1 | ||||
|
Liabilities
|
||||||||
|
Current Liabilities
|
||||||||
|
Trade accounts payable
|
$ | 85.2 | $ | 112.7 | ||||
|
Short-term borrowings
|
130.0 | 126.9 | ||||||
|
Other current liabilities
|
193.3 | 202.7 | ||||||
|
Total current liabilities
|
408.5 | 442.3 | ||||||
|
Long-term debt
|
447.8 | 364.9 | ||||||
|
Other long-term liabilities
|
132.0 | 138.4 | ||||||
|
Total Liabilities
|
988.3 | 945.6 | ||||||
|
Total Shareholders' Equity Attributable to Common Shareholders
|
758.7 | 806.5 | ||||||
|
Noncontrolling Interest
|
10.5 | - | ||||||
|
Total Shareholders' Equity
|
769.2 | 806.5 | ||||||
|
Total Liabilities and Shareholders' Equity
|
$ | 1,757.5 | $ | 1,752.1 | ||||
Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Dollars in millions)
(unaudited)
|
Year to Date Ended June 30
|
||||||||
|
2015
|
2014
|
|||||||
|
Operating Activities
|
||||||||
|
Net income
|
$ | 56.9 | $ | 36.0 | ||||
|
Adjustments to reconcile net income to net cash provided by
|
||||||||
|
operating activities:
|
||||||||
|
Depreciation
|
53.1 | 49.5 | ||||||
|
Amortization
|
8.3 | 9.6 | ||||||
|
Acquisition-related intangible asset amortization
|
23.4 | 20.9 | ||||||
|
Provision for deferred income taxes
|
(12.3 | ) | 4.6 | |||||
|
Loss on disposal of property, equipment leased to others,
|
||||||||
|
intangible assets and impairments
|
- | 7.3 | ||||||
|
Stock compensation
|
14.0 | 13.2 | ||||||
|
Excess tax benefits from employee stock plans
|
(1.7 | ) | 0.5 | |||||
|
Change in working capital excluding cash, current debt,
|
||||||||
|
acquisitions and dispositions:
|
||||||||
|
Trade accounts receivable
|
4.7 | 29.8 | ||||||
|
Inventories
|
(3.4 | ) | (1.2 | ) | ||||
|
Other current assets
|
(5.1 | ) | (4.2 | ) | ||||
|
Trade accounts payable
|
(18.1 | ) | (9.4 | ) | ||||
|
Accrued expenses and other liabilities
|
0.3 | (23.1 | ) | |||||
|
Other, net
|
4.3 | 0.7 | ||||||
|
Net cash provided by operating activities
|
124.4 | 134.2 | ||||||
|
Investing Activities
|
||||||||
|
Capital expenditures and purchases of intangibles
|
(102.6 | ) | (44.4 | ) | ||||
|
Proceeds on sale of property and equipment leased to others
|
1.2 | 1.8 | ||||||
|
Payment for acquisition of businesses, net of cash acquired
|
(5.1 | ) | (15.5 | ) | ||||
|
Refund on acquisition of businesses
|
- | 4.6 | ||||||
|
Other
|
2.1 | 3.2 | ||||||
|
Net cash used in investing activities
|
(104.4 | ) | (50.3 | ) | ||||
|
Financing Activities
|
||||||||
|
Net change in short-term debt
|
(0.7 | ) | (0.2 | ) | ||||
|
Borrowings on revolving credit facility
|
95.0 | 35.0 | ||||||
|
Payments on revolving credit facility
|
- | (40.0 | ) | |||||
|
Proceeds from long-term debt
|
- | 0.6 | ||||||
|
Payment of long-term debt
|
(11.5 | ) | (7.6 | ) | ||||
|
Debt issuance costs
|
(1.6 | ) | - | |||||
|
Purchase of noncontrolling interest of former joint venture
|
(1.6 | ) | (1.3 | ) | ||||
|
Payment of cash dividends
|
(26.7 | ) | (25.4 | ) | ||||
|
Proceeds on exercise of stock options
|
10.2 | 10.2 | ||||||
|
Proceeds from stock issuance
|
2.1 | 1.8 | ||||||
|
Excess tax benefits from employee stock plans
|
1.7 | (0.5 | ) | |||||
|
Treasury stock acquired
|
(57.4 | ) | (71.6 | ) | ||||
|
Net cash provided by (used in) financing activities
|
9.5 | (99.0 | ) | |||||
|
Effect of exchange rate changes on cash
|
(5.4 | ) | (0.4 | ) | ||||
|
Net Cash Flows
|
24.1 | (15.5 | ) | |||||
|
Cash and Cash Equivalents:
|
||||||||
|
At beginning of period
|
99.3 | 127.4 | ||||||
|
At end of period
|
$ | 123.4 | $ | 111.9 | ||||